 Osmotica Pharmaceuticals NASDAQ: OSMT shares were trading higher Monday in anticipation of a ruling by the FDA on the companys New Drug Application for Arbaclofen ER in patients with multiple sclerosis. Osmotica Pharmaceuticals is focused on developing, manufacturing and commercializing specialty products. 